Use of 2 anti-SPARC antibodies to predict response to chemotherapy for pancreatic adenocarcinoma
- 专利权人:
- Abraxis BioScience; LLC
- 发明人:
- Vuong Trieu,Neil Desai,Daniel Knauer
- 申请号：
- US13775980
- 公开号：
- US09091697B2
- 申请日:
- 2013.02.25
- 申请国别(地区):
- US
- 年份:
- 2015
- 代理人:
- 摘要：
- The invention provides anti-SPARC antibody-based techniques for predicting a response to chemotherapy.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- USE OF 2 ANTI-SPARC ANTIBODIES TO PREDICT RESPONSE TO CHEMOTHERAPY
- Use of 2 anti-SPARC antibodies to predict response to chemotherapy
- Use of 2 anti-SPARC antibodies to predict response to melanoma chemotherapy
- PERIPHERAL BLOOD SPARC ANTIBODIES AND USES THEREOF
- Peripheral blood SPARC antibodies and uses thereof
